Www.tissue-solutions.com Focus on NHS/Industry Morag McFarlane, PhD “World Leaders in Human Tissue Provision”

Slides:

Advertisements

Similar presentations

Ann Johnson IRB Administrator, IRB Member. Objectives 1. Identify the components necessary for management and oversight of tissue repositories used for.

Advertisements

TISSUE BANKING Challenging to Say the Least

“Gifting Tissue for Research: An NHS Organisational Challenge”

Unit G: Organ Transplants. Basic facts related to organ transplants A.No age limits – under 18 requires parent or guardian consent A.No age limits – under.

The Human Tissue Act and You Steve Hopkins Designated Individual for Research Tissue

………………..…………………………………………………………………………………………………………………………………….. Biopathology Center The Research Institute at Nationwide Children’s Hospital Dave Billiter,

Leeds Institute of Molecular Medicine Pathology and Tumour Biology Research Tissue Banking Making a GIFT for the future.

The Veterans Affairs Central Biorepository and MVP Highlights Mary T

Map interference lawyer - lawmaker. tree person(s) data associations implications relationships with others.

Practical Issues and Logistics- Tissue Resources and IRB/HIPAA William E. Grizzle Department of Pathology University of Alabama at Birmingham

Biobank Law in Norway – Critical Reflections Body Control – Legal Regulatory Perspectives on Biometrics and Biobanks, University of Oslo November 22-23,

Definitions Biospecimen Uses, Storage Ethical, Legal,

HISTOLOGICAL QUALITY CONTROL OF FROZEN SAMPLES USING MATCHING FFPE TISSUE – PRELIMINARY RESULTS OF OUR INSTITUTIONAL BIOBANK E. Mattioli, E. Foglia Manzillo,

Human tissue: the matter of life and death James Underwood Emeritus Professor of Pathology, The University of Sheffield Member, Human Tissue Authority.

Research ethics in The Netherlands dr Annelien Bredenoord & prof dr Hans van Delden UMC Utrecht Julius Center The Netherlands

Procedures used by CHTN

Engineered Cells and Tissues Locksley McGann, PhD Professor Department of Laboratory Medicine and Pathology University of Alberta 24 April, 2012 Analytics,

TISSUE BIOREPOSITORY AND PATHOLOGY SERVICES. TISSUE PROCUREMENT Routinely collect tumor tissue, adjacent normal tissue, buffy coat, plasma, newly diagnosed.

2nd Quebec Conference on Therapeutic Resistance in Cancer Bienvenue !!!!!

Medical Research BADRAG meeting Jan 2013 Dr H Sari-Kouzel.

Human Research Protection Programs 1a: How to Navigate Human Subject Protection Regulations Sponsored by the American Society for Investigative Pathology.

Thomas J. Bell, PhD Director of Scientific Service.

HOW TO BECOME A WILSON’S DISEASE TISSUE DONOR Advancing the procurement, preservation and distribution of human tissues and organs for biomedical research.

Mesothelioma Collections September 2010 through September 2011.

Data on consent for research with biological samples: toward a uniform approach The views and opinions expressed in this talk are my own. They do not reflect.

©2004 McDermott, Will & Emery. All Rights Reserved. BST Perspectives From Those Who Regulate Tissue Banks: The Moderator’s Perspective Stephen.

Biobanks of Cerice Center for Gene Expression Research in Cancer Epidemiology Eiliv Lund, UiTø.

New Oslo PSC biobank.  Broad consent – covers all clinical and research biobanking  Integrated storage of clinical data and biological material  DNA,

IndianaCTSI ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Building an Indiana Biorepository Dave A Flockhart Eric Meslin April 19 th, 2010.

GENOMIC RESEARCH: INFORMED CONSENT. Genomics- a branch of genetics that sequences DNA to analyze the structure and function of genomes (the complete set.

The short term effects of an AKT inhibitor (AZD5363) on biomarkers of the AKT pathway and anti-tumour activity in a breast cancer paired biopsy study (STAKT.

2011 NYU NMVB Report NYU Dept of Cardiothoracic Surgery NYU Dept of Pathology Monday November 7 th, 2011.

1 ‘Part of the healing:’ Mom tracks impact of organs donated from 6-day-old son Originally published April 5, 2015 at 4:35 pm Within hours of Thomas’ death,

CLIA Waiver for the OraQuick ® Rapid HIV-1 Antibody Test Elliot P. Cowan, Ph.D. Senior Regulatory Scientist Office of Blood Research and Review Center.

Cancer 101: A Cancer Education and Training Program for American Indians & Alaska Natives Cancer 101: A Cancer Education and Training Program for American.

Human Specimen Repositories Requirements of 21 CFR Parts 50 & 56 PRIM & R May 5, 2004 Sally A. Hojvat, Ph.D. Director of Microbiology Devices Office of.

UNM Virtual Human Biospecimen Repository -- Pitfalls and the Possibilities UNM Biocomputing Conference April 22, 2005 Philip J. Kroth, M.D., M.S.

- Is a clear, colorless body fluid.. - bathes the..

Facilitating tissue collection for translational research Jane Rogan Business Manager.

Introduction to UCL Dr Kirstin Goldring (Biobank and BioResource Coordinator)

Research ethics.

Global Cancer Biomarkers Market

 Any place, establishment, or institution that a chain of operations that includes 1. informing patients and obtaining the proper consent, 2. data acquisition,

Retention period(s) of samples/data Many jurisdictions, as well as hospitals and institutions, mandate retention periods for medical or research-related.

Neuroendocrine Tumour Biobank Dr Chrissie Thirlwell Cancer Research UK Clinician Scientist Senior Lecturer Medical Oncology Royal Free Hospital NET Unit.

Tissue Access for Patient Benefit Smoothing the pathway between patients, tissue donation, and research Consent Regulation Logistics Processing Allied.

The Bridge from Patient to Scientist Comparison: BioBank and Cancer Registry Data Source Distinct Patients Percent BioBank % Cancer Registry %

Development of Partnerships:

ZIKA CASES (1/15 -9/7/16) USA- 2,964 total Travel associated 2,920

Tissue Collection & Banking Facility

University of Pennsylvania

ETHICAL ISSUES OF RESEARCH ON HUMAN BIOLOGICAL MATERIALS

Ensuring Successful Technology Transfer for Clinical Manufacture

Research on human biological materials: Lithuanian perspective

Organ and Tissue Transplant

Establishing a Pediatric CNS Biorepository

THE WORLD’S LEADING SOURCE OF TISSUE PROCUREMENT

Organ Donation 9.PCH.1.2: Summarize the procedures for organ donation, local and state resources, and benefits.

Patient information: Research study taking place today

Enabling Biobank Data Exchange

Nathalie BERNARD Marketing Director

Human Tissue Banks Jan Warner.

The Canadian Experience with WNV Testing

Tamar Raz, PHD.

DiagMMR™ assay validation sample collection

GENERAL PATHOLOGY Diagnostic Services in Health Care that apply to the various diseases The role of diagnostics in Healthcare Quality procedures.

Sidney Engelbrecht Manager: Research Ethics OMB, GSH

‘Data ethics and bio-banking’

UAB Tissue Biorepository

Presentation transcript:

Focus on NHS/Industry Morag McFarlane, PhD “World Leaders in Human Tissue Provision”

Provision of quality human tissues and other biological materials Prospective collections & off-the shelf-rapid access The right material for the right experiment Delivered in a timely fashion Using a large network of sources worldwide Full commercial rights to all samples Compliant with the highest international ethical requirements Your Virtual Biobank

Types of Tissue Fresh Surgical Excess or PM Biopsies Other Biomaterials - Blood, urine, CSF etc Frozen (FF or OCT) FFPE Matched Pairs Detailed clinical annotations Long term follow up data Low ischemia time Cells Custom Procurement Routine Samples

Who do we support?

Strength in our Network All sources vetted IRB or ethics committee approval Written consent of donors Respect & dignity for tissue samples & donors UK, Europe, Australia & USA Commercial biobanks Not for profit tissue banks Hospitals Brain bank Organ donor programs NRES Research Tissue Bank Skin, bloods, urine, saliva, faeces etc

Case Study NRES approved Virtual Tissue Bank License Fresh skin biopsies and matching bloods Fresh bloods from tightly defined diseased groups Fresh bloods for companion diagnostic validation Fresh saliva, urine, faeces for diagnostics development Fresh normal skin for regulatory testing

Room for improvement Current project Who is the correct contact? Commercial timelines?

Morag McFarlane, PhD +44(0) Thanks for your time!